IL-10, But Not IL-4, Suppresses Infection-Stimulated Bone Resorption In Vivo1
暂无分享,去创建一个
[1] K. Balto,et al. Quantification of Periapical Bone Destruction in Mice by Micro-computed Tomography , 2000, Journal of dental research.
[2] M. Konstan,et al. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. , 1999, American journal of respiratory and critical care medicine.
[3] Kawashima,et al. Infection‐stimulated infraosseus inflammation and bone destruction is increased in P‐/E‐selectin knockout mice , 1999, Immunology.
[4] J. Pelletier,et al. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. , 1999, Arthritis and rheumatism.
[5] T. Hamilton,et al. Cutting edge: clustered AU-rich elements are the target of IL-10-mediated mRNA destabilization in mouse macrophages. , 1999, Journal of immunology.
[6] H. Weiner,et al. IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.
[7] M. Kopf,et al. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. , 1998, Journal of immunology.
[8] A. Tumber,et al. The cellular actions of interleukin-11 on bone resorption in vitro. , 1998, Endocrinology.
[9] H. Tilg,et al. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.
[10] C. Y. Wang,et al. Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections , 1997, Infection and immunity.
[11] C. Y. Wang,et al. Bone-resorptive cytokine gene expression in periapical lesions in the rat. , 1997, Oral microbiology and immunology.
[12] M. Hernández-Garay,et al. Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells , 1997, Clinical and diagnostic laboratory immunology.
[13] B. Groner,et al. IL‐10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes , 1996, FEBS letters.
[14] Y. Ohmori,et al. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. , 1996, Journal of immunology.
[15] T. Chambers,et al. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. , 1996, Journal of immunology.
[16] M. Mochizuki,et al. Suppression by IL-10 and IL-4 of cytokine production induced by two-way autologous mixed lymphocyte reaction. , 1996, Cytokine.
[17] W. Domschke,et al. Immunoregulatory properties of IL‐13 in patients with inflammatory bowel disease; comparison with IL‐4 and IL‐10 , 1996, Clinical and experimental immunology.
[18] T. Bártfai,et al. Subchronic glucocorticoid pretreatment reversibly attenuates IL-1β induced fever in rats; IL-6 mRNA is elevated while IL-1α and IL-1β mRNAs are suppressed, in the CNS , 1996 .
[19] S. Nozawa,et al. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. , 1996, Journal of immunology.
[20] A. Kukita,et al. Interleukin‐10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast‐like cells in rat bone marrow culture system , 1995, Journal of cellular physiology.
[21] Y. Koishihara,et al. Endogenous bone‐resorbing factors in estrogen deficiency: Cooperative effects of IL‐1 and IL‐6 , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] C. Y. Wang,et al. Immunolocalization of bone-resorptive cytokines in rat pulp and periapical lesions following surgical pulp exposure. , 1995, Oral microbiology and immunology.
[23] P. Hart,et al. Monocytes cultured in cytokine‐defined environments differ from freshly isolated monocytes in their responses to IL‐4 and IL‐10 , 1995, Journal of leukocyte biology.
[24] S. Schreiber,et al. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. , 1995, Gastroenterology.
[25] Peng Wang,et al. Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.
[26] I. Otterness,et al. Neutralization of endogenous IL-6 suppresses induction of IL-1 receptor antagonist. , 1995, Journal of immunology.
[27] B. Dewald,et al. Interleukin‐10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts , 1995, European journal of immunology.
[28] J. Economou,et al. Interleukin‐4 inhibits the expression of tumour necrosis factors α and β, interleukins‐1 β and ‐6 and interferon‐γ , 1995 .
[29] J. Banchereau,et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[30] M. Murtaugh,et al. Interleukin‐4 suppresses inflammatory cytokine gene transcription in porcine macrophages , 1994, Journal of leukocyte biology.
[31] C. Y. Wang,et al. Pathogenesis of induced rat periapical lesions. , 1994, Oral surgery, oral medicine, and oral pathology.
[32] M. Billah,et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. , 1994, Journal of immunology.
[33] D. Lacey,et al. Interleukin-4 inhibits bone resorption and acutely increases cytosolic Ca2+ in murine osteoclasts. , 1994, The Journal of biological chemistry.
[34] H. Niiro,et al. IL-10 inhibits prostaglandin E2 production by lipopolysaccharide-stimulated monocytes. , 1994, International immunology.
[35] J. Riancho,et al. Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures. , 1993, Biochemical and biophysical research communications.
[36] K. Kasono,et al. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. , 1993, Bone and mineral.
[37] M. Howard,et al. Modified immunological status of anti-IL-10 treated mice. , 1993, Cellular immunology.
[38] M. Lotze,et al. Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo , 1993, The Journal of experimental medicine.
[39] C. Y. Wang,et al. The role of interleukin-1 alpha in the pathogenesis of periapical bone destruction in a rat model system. , 1993, Oral microbiology and immunology.
[40] Y. Abiko,et al. Stimulation by interleukin-1 of interleukin-6 production by human periodontal ligament cells. , 1992, Archives of oral biology.
[41] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[42] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[43] D. Lacey,et al. Interleukin 4 inhibits murine osteoclast formation in vitro , 1991, Journal of cellular biochemistry.
[44] T. Mosmann,et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. , 1991, Journal of immunology.
[45] J. Kaufman,et al. IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4. , 1991, Journal of immunology.
[46] T. Hirano,et al. IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.
[47] G. Tosato,et al. Interleukin-1 induces interleukin-6 production in peripheral blood monocytes. , 1990, Blood.
[48] C. Libert,et al. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice , 1990, European journal of immunology.
[49] F. Dewhirst,et al. Interleukin‐1β is a potent inhibitor of bone formation in vitro , 1987 .
[50] T. Bringman,et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.
[51] R. Russell,et al. An interleukin 1 like factor stimulates bone resorption in vitro , 1983, Nature.
[52] N. Kawashima,et al. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. , 1999, Archives of oral biology.
[53] S. Akira,et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. , 1999, Immunity.
[54] R. D'Souza,et al. Periapical inflammatory responses and their modulation. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[55] M. Billah,et al. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. , 1995, The Journal of biological chemistry.
[56] H. Tilg,et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.
[57] C. Dinarello,et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.
[58] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.